Valeant Pharmaceuticals International Inc. bears are betting the stock has further to fall. Last week, short interest as a percentage of shares outstanding spiked almost a full percentage point in one day. The surge in shorts pushed the measure to its highest level since April, a tumultuous period that saw the company review its strategic options and name a new chief executive officer.
Before it's here, it's on the Bloomberg Terminal. LEARN MORE